Mohammed Khurshed

Radioprotection of <i>IDH1</i> -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198

Remco J. Molenaar, Dennis Botman, Myrthe A J Smits et al. · Cancer Research · 2015 · 144 citations

Medicine, Cancer Biology, Oncology +17

<i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors

Remco J. Molenaar, Tomas Radivoyevitch, Yasunobu Nagata et al. · Clinical Cancer Research · 2018 · 104 citations · Full text

Medicine, Molecular Biology, Oncology +13

Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with <i>IDH1</i> -mutated or <i>IDH2</i> -mutated solid tumours

Remco J. Molenaar, Robert J.S. Coelen, Mohammed Khurshed et al. · BMJ Open · 2017 · 79 citations · Full text

Medicine, Oncology, Pharmacology +14

<i>In silico</i> gene expression analysis reveals glycolysis and acetate anaplerosis in <i>IDH1</i> wild-type glioma and lactate and glutamate anaplerosis in <i>IDH1</i>-mutated glioma

Mohammed Khurshed, Remco J. Molenaar, Krissie Lenting et al. · Oncotarget · 2017 · 69 citations · Full text

Medicine, Genetics, Oncology +17

Comparison of different methodologies and cryostat versus paraffin sections for chromogenic immunohistochemistry

Vashendriya V.V. Hira, Annique Loncq de Jong, Klea Ferro et al. · Acta Histochemica · 2018 · 55 citations · Full text

Medicine, Pathology, Histopathology +15